Drug Database · Clinicians

Telmisartan

Brands (202) Merit, Micardis, Telmez…Show all
Merit · Micardis · Telmez · Mistel · T-Sartan · Telguard · Telisolv · Terasart · Beisartan · Corzap · Hardis · Maxitel · Micargen · Misar · Misartan 40 · Misartan 80 · Neo-Sar · Onmarc · OP-Telmis · Rhandesartan · Telarb · Telatraz · Teldra · Telgio · Telgip · Telman · Telmax · Telmibet · Telmicor · Telmidin · Telmierra · Telmiget · Telmijaz · Terlisartan · Tesar · Vas8 · Vicardis · Xytel · Zermisar · Actarb 40 · Actarb 80 · Ajesart · Amilozart · Amisar 40 · ARB · ARB DS · Arbitel -40 · Arbitel-80 · Cardetres · Cardimis · Cardiozart-40 · Cardiozart-80 · Cardizar · Curatel · Edzar · Emzart 40 · Emzart 80 · Estellar 40 · Estellar 80 · Glo-Sartan 40 · Glo-Sartan 80 · Glosartan 40 · Glosartan 80 · Jestsartan · Mabisar · Macsart 40 · Macsart 80 · Mevo 40 · Mevo 80 · Mezartel-20 · Mezartel-40 · Mezartel-80 · Micarmed · Micas · Micavid 40 · Micavid 80 · Micor · Misart · Misarven 80 · Mistacor 40 · Mistacor 80 · Mizar · Mycartan-40 · Mycartan-80 · Myzart 40 · N-Blood 40 · N-Blood 80 · Normitech · Novazart · Oppisartan-40 · Oppisartan-80 · Oratel-40 · Oratel-80 · Retaguard 40 · Retaguard 80 · Rhetizar · Saphmis-GE40 · Saphmis-GE80 · Tartan 40 · Tartan 80 · Telbip 40 · Telcor 40 · Telcor 80 · Telday-40 · Telday-80 · Telfocus 40 · Telfocus 80 · Telfort 40 · Telfort 80 · Telgrand-40 · Teli 40 · Teli 80 · TeliDril 20 · TeliDril 40 · Telidril 80 · TeliGen-20 · TeliGen-40 · TeliGen-80 · Telimac 40 · Telimac 80 · Telisan 40 · Telisan 80 · Telmaxa-80 · Telmefixx · Telmicard-20 · Telmicard-40 · Telmicass · Telmicura 40 · Telmicura 80 · Telmidec-40 · Telmidec-80 · Telmidis-40 · Telmidiv - 80 · Telmiem 40 · Telmiem 80 · Telmifast 40 · Telmiflex-40 · Telmiflex-80 · Telmigen · Telmignan-40 · Telmiheart 40 · Telmiheart 80 · Telminex-40 · Telminex-80 · Telminorm-80 · Telminow 40 · Telminow 80 · Telmiphil · Telmira · Telmirich · Telmiride-40 · Telmiride-80 · Telmirin 80 · Telmirx 40 · TELMISAPH-40 · Telmisaph-80 · Telmisar · Telmisar 80 · Telmispec · Telmistal-40 · Telmistal-80 · Telmitar 40 · Telmitar 80 · Telmitime · Telmivasc · Telmiver-40 · Telmiver-80 · Telmixed · Telmizart · Telmizen 40 · Telmyr-40 · TELOD 80 · Telsar 40 · Telsar-80 · Telsartan · Telsartin 40 · Telsartin 80 · Telsicare · Telsicare-80 · Telsitan-20 · Telsitan-40 · Telsitan-80 · Telstar 40 · Telstar 80 · Telsyn · Teltan · Telvakon-40 · Telvesta · Telwin 40 · Telwin 80 · Telzel · Telzyd 20 · Telzyd 40 · Telzyd 80 · Tenomex · Tesarmiz · Tevex 40 · Tevex 80 · Tevilyst 80 · Thelz-80 · Tsartan 40 · Tsartan 80

Angiotensin 2 Receptor Blocker (Angiotensin 2 Receptor Antagonists) US FDA class
Angiotensin II receptor blocker (ARB); Angiotensin II antagonist receptor blocker (ARB); and others PH FDA category

Rx · Prescription drug295 PH productsPNF-listedPhilHealth GAMOTVAT-exempt
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 5743c58e-deab-ac93-e063-6294a90ac1eb, version date July 23, 2026 (Telmisartan · Redpharm Drug). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Treatment of hypertension, to lower blood pressure.
  • Cardiovascular (CV) risk reduction in patients unable to take ACE inhibitors
US FDA label
Full indications and usage US FDA label

1 INDICATIONS AND USAGE Telmisartan tablets are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1) Cardiovascular (CV) risk reduction in patients unable to take ACE inhibitors (1.2) 1.1 Hypertension Telmisartan tablets are indicated for the treatment of hypertension, to lower blood pressure.

Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake.

Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy. Telmisartan tablets may be used alone or in combination with other antihypertensive agents [see Clinical Studies (14.1)]. 1.2 Cardiovascular Risk Reduction Telmisartan tablets are indicated for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take ACE inhibitors.

High risk for cardiovascular events can be evidenced by a history of coronary artery disease, peripheral arterial disease, stroke, transient ischemic attack, or high-risk diabetes (insulin-dependent or non-insulin dependent) with evidence of end-organ damage [see Clinical Studies (14.2)]. Telmisartan tablets can be used in addition to other needed treatment (such as antihypertensive, antiplatelet or lipid-lowering therapy) [see Clinical Studies (14.2)].

Studies of telmisartan in this setting do not exclude the possibility that telmisartan may not preserve a meaningful fraction of the effect of the ACE inhibitor to which it was compared. Consider using the ACE inhibitor first, and, if it is stopped for cough only, consider re-trying the ACE inhibitor after the cough resolves.

Use of telmisartan with an ACE inhibitor is not recommended [see Warnings and Precautions (5.6)].

Contraindications

4 CONTRAINDICATIONS Telmisartan tablets are contraindicated in patients with known hypersensitivity (e.g., anaphylaxis or angioedema) to telmisartan or any other component of this product [see Adverse Reactions (6.2)]. Do not co-administer aliskiren with telmisartan in patients with diabetes [see Drug Interactions (7)]. Known hypersensitivity (e.g., anaphylaxis or angioedema) to telmisartan or any other component of this product (4) Do not co-administer aliskiren with telmisartan in patients with diabetes (4)

US FDA label

Dosing: Adult

Dosage and administration (US label) US FDA label
  • May be administered with or without food (2.1)
  • When used for cardiovascular risk reduction, monitoring of blood pressure is recommended, and if appropriate, adjustment of medications that lower blood pressure may be necessary (2.2)
  • Indication Starting Dose Dose Range Hypertension (2.1)
  • 40 mg once daily 40 to 80 mg once daily Cardiovascular Risk Reduction (2.2)
  • 80 mg once daily 80 mg once daily
2.1 Hypertension

2.1 Hypertension Dosage must be individualized. The usual starting dose of telmisartan tablets is 40 mg orally once a day. Blood pressure response is dose-related over the range of 20 to 80 mg [see Clinical Studies (14.1)]. Most of the antihypertensive effect is apparent within 2 weeks and maximal reduction is generally attained after 4 weeks.

No initial dosage adjustment is necessary for elderly patients or patients with renal impairment, including those on hemodialysis. Patients on dialysis may develop orthostatic hypotension; their blood pressure should be closely monitored. Telmisartan tablets may be administered with other antihypertensive agents. Telmisartan tablets may be administered with or without food.

2.2 Cardiovascular Risk Reduction

2.2 Cardiovascular Risk Reduction The recommended dose of telmisartan tablets are 80 mg once a day and can be administered with or without food. It is not known whether doses lower than 80 mg of telmisartan are effective in reducing the risk of cardiovascular morbidity and mortality. When initiating telmisartan tablets therapy for cardiovascular risk reduction, monitoring of blood pressure is recommended, and if appropriate, adjustment of medications that lower blood pressure may be necessary.

Dosing: Altered kidney function

From the US FDA label · Renal impairment (pharmacokinetics)

Renal Insufficiency No dosage adjustment is necessary in patients with decreased renal function. Telmisartan is not removed from blood by hemofiltration and is not dialyzable [see Warnings and Precautions (5.5) and Dosage and Administration (2.1)].

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosing: Hepatic impairment

8.6 Hepatic Insufficiency Monitor carefully and uptitrate slowly in patients with biliary obstructive disorders or hepatic insufficiency [see Warnings and Precautions (5.4)].

US FDA label

Dosing: Pediatric

Pediatric use (US label) US FDA label

8.4 Pediatric Use Safety and effectiveness in pediatric patients have not been established [see Clinical Pharmacology (12.3)]. Neonates with a history of in utero exposure to telmisartan If oliguria or hypotension occurs, support blood pressure and renal perfusion. Exchange transfusions or dialysis may be required as a means of reversing hypotension and/or substituting for disordered renal function.

Dosing: Older adult

Geriatric use (US label) US FDA label

8.5 Geriatric Use Of the total number of patients receiving telmisartan in hypertension clinical studies, 551 (19%) were 65 to 74 years of age and 130 (4%) were 75 years or older. No overall differences in effectiveness and safety were observed in these patients compared to younger patients and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.

Of the total number of patients receiving telmisartan tablets in the cardiovascular risk reduction study (ONTARGET), the percentage of patients ≥65 to <75 years of age was 42%; 15% of patients were ≥75 years old. No overall differences in effectiveness and safety were observed in these patients compared to younger patients and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.

Dosage forms

Philippines

  • Tablet: 20 mg, 40 mg, 80 mg
  • Film-coated tablet: 20 mg, 40 mg, 80 mg

Registered products in the Philippines

295 products registered with the Food and Drug Administration (FDA) Philippines list Telmisartan as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products295
Philippine FDA-registered products for Telmisartan
Package insert
Actarb 40Telmisartan
40 mg TabletStore at temperatures not exceeding 30°C
RxVAT-exempt
Sun Pharmaceutical Industries LimitedIndia
Sun Pharma Philippines, Inc.
DRP-12828
Jun 4, 2030
Actarb 80Telmisartan
80 mg TabletAlu/Alu blister pack x 10's (Box of 30's)
RxVAT-exempt
Village Ganguwala, Paonta Sahib, District Sirmour, Himachal Prasdesh 173025, IndiaIndia
Sun Pharma Philippines, Inc.
DRP-12827
Jun 4, 2030
AjesartTelmisartan
80 mg TabletAlu/Alu blister pack x 10 tablets (Box of 30 tablets)
RxVAT-exempt
Actavis Ltd.Malta
AJ Research & Pharma, Inc.Importer: AJ Research & Pharma
DR-XY47894
Apr 4, 2027
AmilozartTelmisartan
40 mg TabletAlu/Alu Blister Pack x l0's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-16792-01
Jul 11, 2030
Amisar 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
St. Raphael's Healing Ventures Incorporated doing business under the name/s and style/s of The Healers' Pharmaceutical and Medical Supplies DistributorshipImporter: Orange Biotec Inc.
DRP-3212-10
Aug 24, 2029
ARBTelmisartan
40 mg Film-Coated TabletAluminum Strip Pack x 10's (Box of 30's)
RxVAT-exempt
Corona Remedies Pvt. Ltd.India
Iberica Verheilen Pharmaceuticals Group Corp.Importer: Verheilen Iberica Health Care Company, Inc.Trader: Farma Iberica SL
DRP-14837
Jan 19, 2029
ARB DSTelmisartan
80 mg Film-Coated TabletAluminum Strip Pack x 10's (Box of 30's)
RxVAT-exempt
Corona Remedies Pvt. Ltd.India
Iberica Verheilen Pharmaceuticals Group Corp.Importer: Verheilen Iberica Health Care Company Inc.Trader: Farma Iberica S.L.
DR-XY47064
Sep 21, 2030
Arbitel -40Telmisartan
40 mg TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Phils., Inc.
DR-XY49723
May 18, 2032
Arbitel-80Telmisartan
80 mg TabletAlu-Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Phils., Inc.
DR-XY49722
May 18, 2032
BeisartanTelmisartan
40 mg TabletAlu/Alu blister pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-15838
Sep 20, 2029
BeisartanTelmisartan
80 mg TabletAlu/Alu blister pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-15839
Sep 20, 2029
CardetresTelmisartan
40 mg TabletAlu / Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Healer's Lab (Unit II)India
NAB Trading Corp.Importer: Pharmakon Biotec Inc.
DRP-5421-13
Aug 5, 2029
CardimisTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Pharmakon Biotec Inc.
DRP-16792
Jul 11, 2030
Cardiozart-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Applied Pharmaceutical Distribution Inc.Importer: Orange Biotec Inc.
DRP-3212-04
Aug 24, 2029
Cardiozart-80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Applied Pharmaceutical Distribution Inc.Importer: Orange Biotec Inc.
DRP-3207-02
Aug 24, 2029
CardizarTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Corbridge Group Phils., Inc.Importer: Orange Biotec Inc.
DRP-3212-05
Aug 24, 2029
CorzapTelmisartan
40 mg TabletAlu (PVC/Alu/OPA)/ Alu Blister Pack of 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Globela Pharma Private LimitedIndia
Helande Kidney Care Inc.Importer: AMB HK Enterprises Inc.
DRP-10475-07
Sep 30, 2031
CorzapTelmisartan
80 mg TabletAlu (PVC/Alu/OPA)/ Alu Blister Pack of 10’s Box of 30’s and 100’s
RxVAT-exempt
Globela Pharma Private LimitedIndia
Helande Kidney Care Inc.Importer: AMB HK Enterprises Inc.
DRP-10476-06
Sep 30, 2031
CuratelTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Healer's Lab Unit IIIndia
Curasave PharmaImporter: Pharmakon Biotec Inc.
DRP-5421-11
Aug 5, 2029
EdzarTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's And 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.,Philippines
—
DRP-18308
Jun 16, 2031
Emzart 40Telmisartan
40 mg TabletAlu (PVC/Alu/OPA)/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Globela Pharma Private LimitedIndia
Emcure Pharma Philippines Inc.Importer: AMB HK Enterprises Inc
DRP-10475-08
Sep 30, 2031
Emzart 80Telmisartan
80 mg TabletAlu (PVC/Alu/OPA)/ Alu Blister Pack of 10’s Box of 30’s
RxVAT-exempt
Globela Pharma Private LimitedIndia
Emcure Pharma Philippines Inc.Importer: AMB HK Enterprises Inc.
DRP-10476-07
Sep 30, 2031
Estellar 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, IncPhilippines
Trader: Justright Healthcare Inc
DR-XY49735
May 25, 2031
Estellar 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, IncPhilippines
Trader: Justright Healthcare Inc
DR-XY49733
May 25, 2031
Glo-Sartan 40Telmisartan
40 mg Film-coated TabletAlu-PVC Blister Pack of 14’s in a polyester/aluminum/polyethylene bag Alu-PVC Blister Pack of 10’s in a polyester/aluminum/polyethylene bag (Box of 28’s and 30’s)
RxVAT-exempt
Zhejiang Jingxin Pharmaceutical Co., Ltd.China
PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-17052-01
Sep 15, 2030
Glo-Sartan 80Telmisartan
80 mg Film-coated TabletAlu/PVC Blister Pack x 10's in a Polyester/Aluminum/Polyethylene Bag (Box of 30’s)
RxVAT-exempt
Zhejiang Jingxin Pharmaceutical Co., Ltd.China
PhilRx Pharma, Inc.Importer: AMB HK Enterprises, Inc.
DRP-17053-01
Sep 15, 2030
Glosartan 40Telmisartan
40 mg TabletAlu (PVC/Alu/OPA)/Alu Blister Pack of 10's (Box of 30's); Alu (PVC/Alu/OPA)/Alu Blister Pack of 10's (Box of 100's)
RxVAT-exempt
Globela Pharma Private LimitedIndia
AMB HK Enterprises Inc.
DRP-10475
Sep 30, 2031
Glosartan 80Telmisartan
80 mg TabletAlu (PVC/Alu/OPA)/Alu Blister Pack of 10's
RxVAT-exempt
Globela Pharma Private LimitedIndia
Amb Hk Enterprises Inc.
DRP-10476
Sep 26, 2031
HardisTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Harlem SalesImporter: Philgen Pharmaceuticals Inc.
DRP-11041-04
Jan 12, 2027
HardisTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Harlem SalesImporter: Philgen Pharmaceuticals Inc.
DRP-11040-04
Jan 12, 2027
JestsartanTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Boon Pharma CorpImporter: Orange Biotec Inc.
DRP-3212-18
Aug 24, 2029
MabisarTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Medconcern Drugs and General Merchandise Inc.Importer: Orange Biotec Inc.
DRP-3212-12
Aug 24, 2029
Macsart 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and and 100's)
RxVAT-exempt
Macleods Pharmaceuticals Limited.India
Genedrift Philippines OPC
DRP-15386
Jul 1, 2029
Macsart 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Macleods Pharmaceuticals LimitedIndia
Genedrift Philippines OPC
DRP-15385
Jul 1, 2029
MaxitelTelmisartan
20 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DRP-12870
Dec 14, 2027
MaxitelTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DRP-14304
Aug 16, 2028
MeritTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Intas Pharmaceuticals LimitedIndia
Unilab, Inc.Importer: Ritemed Phils., Inc.
DRP-11048-01
Jan 19, 2027
MeritTelmisartan
40 mg TabletAlu-Alu/OPA/PVC Blister Pack x 7's (Box of 28's)
RxVAT-exempt
Krka, d.d., Novo mestoSlovenia
UNILAB, Inc.
DRP-12707
Sep 27, 2027
MeritTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Cadila Pharmaceuticals LimitedIndia
Unilab, Inc.Importer: Ambica International Corporation
DRP-4789-02
Oct 4, 2028
MeritTelmisartan
40 mg TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Evertogen Life Sciences LimitedIndia
UNILAB, Inc.Importer: MEDINOVA PHARMACEUTICAL INC.
DRP-8339-03
May 7, 2029
MeritTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Intas Pharmaceuticals LimitedIndia
UNILAB, INC.Importer: Ritemed Phils., Inc.
DRP-11047-01
Jan 19, 2027
MeritTelmisartan
80 mg TabletAlu-Alu/OPA/PVC Blister Pack x 7's (Box of 28's)
RxVAT-exempt
Krka, d. d., Novo mestoSlovenia
UNILAB, Inc.
DRP-12703
Sep 27, 2027
MeritTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Cadila Pharmaceuticals LimitedIndia
Unilab, Inc.Importer: Ambica International Corporation
DRP-4790-02
Oct 4, 2028
MeritTelmisartan
80mg TabletAlu-Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Evertogen Life Sciences LimitedIndia
UNILAB, Inc.Importer: MEDINOVA PHARMACEUTICAL INC.
DRP-8338-03
May 7, 2029
Mevo 40Telmisartan
40 mg TabletAlu (PVC/Alu/OPA)/ Alu Blister Pack of 10’s (Box of 30’s)
RxVAT-exempt
Globela Pharma Private LimitedIndia
FSPC Pharmaceuticals, Inc.Importer: AMB HK Enterprises Inc.
DRP-10475-01
Sep 30, 2031
Mevo 80Telmisartan
80 mg TabletAlu (PVC/Alu/OPA)/ Alu Blister Pack of 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Globela Pharma Private LimitedIndia
FSPC Pharmaceuticals Inc.Importer: AMB HK Enterprises Inc.
DRP-10476-03
Sep 30, 2031
Mezartel-20Telmisartan
20 mg Film Coated TabletAlu-Alu Blister Pack x 10's and Box of 100's (Box of 1)
RxVAT-exempt
Macter International Ltd.Pakistan
Amson PharmaceuticalsImporter: Sahar International Trading Inc.
DRP-10270-01
Jan 20, 2032
Mezartel-40Telmisartan
40 mg Film Coated TabletAlu/Alu Blister pack x 10's Box of10's and Box of 100's
RxVAT-exempt
Macter International LtdF-S.I.T.E Karachi 75700 Pakistan
Amson PharmaceuticalsImporter: Sahar International Trading Inc.
DR-12323-01
Jun 30, 2031
Mezartel-80Telmisartan
80 mg Film-Coated TabletAlu-Alu blister pack x 10's and 100's (Box of 10's and Box of 100's)
RxVAT-exempt
Macter International Ltd.Pakistan
Amson PharmaceuticalsImporter: Sahar International Trading Inc.
DRP-10266-01
Dec 1, 2030
MicardisTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Boehringer Ingelheim Pharma GmbH & Co. KGGermany
Importer: Boehringer Ingelheim (Philippines), Inc.
DRP-7825
Oct 30, 2027
MicardisTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's); Alu/Alu Blister Pack x 7's (Box of 7's) (as Physician's Sample)
RxVAT-exempt
Boehringer Ingelheim Hellas Single Member S.A.Greece
Importer: Boehringer Ingelheim (Philippines), Inc.
DRP-9597
Mar 17, 2031
MicardisTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Boehringer Ingelheim Pharma GmbH & Co. KGGermany
Importer: Boehringer Ingelheim (Philippines), Inc.
DRP-7826
Oct 4, 2027
MicardisTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Boehringer Ingelheim Hellas Single Member S.A.Greece
Importer: Boehringer Ingelheim (Philippines), Inc.
DRP-9596
Mar 17, 2031
MicargenTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Healer's Lab. Unit IIIndia
Alternative Platform Exchange, Inc.Importer: Pharmakon Biotec Inc.
DRP-5421-09
Aug 5, 2029
MicargenTelmisartan
40mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Evertogen Life Sciences LimitedIndia
Alternative Platform Exchange, Inc.Importer: Medinova Pharmaceutical Inc.
DRP-8339-05
May 7, 2029
MicarmedTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Pelltech Health Care Private LTD.India
Dreamax IncorporatedTrader: Medior Healthcare Pvt. Ltd.
DRP-18989
Oct 14, 2031
MicasTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Rule Med Pharma Corp.Importer: Orange Biotec Inc.
DRP-3212-17
Aug 24, 2029
Micavid 40Telmisartan
40 mg TabletOPA/Alu/PVC Blister x 10's Box of 30's
RxVAT-exempt
Jubilant Generics LimitedIndia
Hovid Inc.Trader: Hovid Bhd.
DR-XY46681
Aug 19, 2029
Micavid 80Telmisartan
80 mg TabletOPA/Alu/PVC Blister x l0's (Box of30's)
RxVAT-exempt
Jubilant Generics LimitedIndia
Hovid Inc.Trader: Hovid Bhd.
DR-XY46680
Aug 19, 2029
MicorTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Healer's Lab. Unit IIIndia
Pharmakon Biotec Inc.
DRP-5421
Aug 5, 2029
MisarTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Orange Biotec Inc.
DRP-3212
Aug 24, 2029
MisarTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Orange Biotec Inc.
DRP-3207
Aug 24, 2029
MisartTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
East African (India) OverseasIndia
Airlife International Trading Corporation.Importer: Airlife International Trading Corporation
DRP-15376
Jun 28, 2029
Misartan 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Philgen Pharmaceuticals Inc.
DRP-11041-00
Jan 12, 2027
Misartan 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
TGP Pharma Inc.Importer: Philgen Pharmaceuticals Inc.Trader: Â
DRP-11041-01
Jan 12, 2027
Misartan 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Philgen Pharmaceuticals Inc.
BRP-260971-01
Jan 12, 2027
Misartan 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
TGP Pharma Inc.Importer: Philgen Pharmaceuticals Inc.
DRP-11040-01
Jan 12, 2027
Misarven 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Healol Pharma Corporation
DRP-14585
Oct 19, 2028
Mistacor 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10’s (Box of 30’s); Alu/Alu Blister Pack x 10’s (Box of 30’s as Physician’s Sample); Alu/Alu Blister Pack x 10’s (Box of 2’s, 5’s and 10’s as Physician’s Sample)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Diafarm, Inc.Importer: Ambica International Corporation
DRP-3687-06
May 3, 2032
Mistacor 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10’s (Box of 10’s); Alu/Alu Blister Pack x 10’s (Box of 2’s, 5’s & 10’s as Physician’s Sample)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-3710-05
Mar 29, 2032
MistelTelmisartan
40 mg TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Nucare Labs LLP.India
ECE Pharmaceuticals, Inc.Importer: Biophil Medical Equipment and Supplies Trading
DRP-16140
Nov 12, 2029
MistelTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Healer's Lab. Unit IIIndia
ECE Pharmaceuticals, Inc.Importer: Pharmakon Biotec Inc.
DRP-5421-01
Aug 5, 2029
MistelTelmisartan
80 mg TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Nucare Labs LLPIndia
ECE Pharmaceuticals, Inc.Importer: Biophil Medical Equipment and Supplies Trading
DRP-16103
Oct 31, 2029
MizarTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Willore Pharma Corporation
DRP-6742-02
Mar 23, 2030
Mycartan-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Evertogen Life Sciences LimitedIndia
AMEDIQO PHILS., INC.Importer: MEDINOVA PHARMACEUTICAL INC.
DRP-8339-01
May 7, 2029
Mycartan-80Telmisartan
80 mg TabletAlu-Alu Blister Pack of 10's (Box of 30's)
RxVAT-exempt
Evertogen Life Sciences LimitedIndia
AMEDIQO PHILS., INC.Importer: MEDINOVA PHARMACEUTICAL INC.
DRP-8338-02
May 7, 2029
Myzart 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Evertogen Life Sciences LimitedIndia
Neo Care Philippines, Inc.Importer: Medinova Pharmaceutical Inc.
DRP-8339-07
May 7, 2029
N-Blood 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Cadila Pharmaceuticals LimitedIndia
Diafarm Inc.Importer: Ambica International Corporation
DRP-4789-01
Oct 4, 2028
N-Blood 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Cadila Pharmaceuticals LimitedIndia
Diafarm Inc.Importer: Ambica International Corporation
DRP-4790-01
Oct 4, 2028
Neo-SarTelmisartan.
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
The Acme Laboratories LimitedBangladesh
Sea-King Pharma Inc.
DR-XY49412
Jun 3, 2030
Neo-SarTelmisartan
40 mg TabletAlu / Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
The ACME Laboratories LimitedBangladesh
Euro Generics International Phils., Inc.
DRP-17531
Jun 3, 2030
NoneTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
—
DR-XY44116
Jan 23, 2030
NoneTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Bansan Pharma DistributorImporter: Philgen Pharmaceuticals Inc.
DRP-11041-05
Jan 12, 2027
NoneTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
TGP Pharma Inc.Importer: Philgen Pharmaceuticals Inc.
DRP-11041-3
Jan 12, 2027
NoneTelmisartan
40 mg TabletAluminum Foil Strip x 10's (Box of 30's)
RxVAT-exempt
Drugmaker's Laboratories Inc.Philippines
—
DRP-11533
Jun 5, 2031
NoneTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
St. Joseph DrugstoreTrader: Solvang Pharmaceuticals, Inc.
DRP-14379-01
Aug 31, 2028
NoneTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
South Star DrugTrader: Dr. Zen's Research, Inc.
DRP-14388-01
Aug 31, 2028
NoneTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Cyden Medicale Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-16792-11
Jul 11, 2030
NoneTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
PharmaVital Corp.Importer: Ambica International Corporation
DRP-3687-10
May 3, 2027
NoneTelmisartan
40 mg TabletAlu/Alu Blister Pack of 3's x 10's (Box of 30's)
RxVAT-exempt
Scott-Edil Pharmacia Ltd.India
Alkem Laboratories CorporationImporter: Pharmakon Biotec Inc.
DRP-4765-08
Sep 30, 2028
NoneTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Healer's Lab. Unit IIIndia
Zydus Healthcare Philippines Inc.Importer: Pharmakon Biotec Inc.
DRP-5421-10
Aug 5, 2029
NoneTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
—
DRP-6176
Jan 23, 2030
NoneTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10’s (Box of 50’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Actimed, Inc.Importer: Ambica International Corporation
DRP-6364-01
Oct 2, 2030
NoneTelmisartan
40 mg TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Evertogen Life Sciences LimitedIndia
RITEMED PHILS., INC.Importer: MEDINOVA PHARMACEUTICAL INC.
DRP-8339
May 7, 2029
NoneTelmisartan
40mg TabletTriple Laminated cold form Alu/Alu Blsiter Pack x 10's (Box of 30's)
RxVAT-exempt
Aurobindo Pharma Limited (Unit VII)India
Medethix, Inc.
DRP-13448
Feb 22, 2031
NoneTelmisartan
80 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 10's, 30’s and 100's)
RxVAT-exempt
Macter International Ltd.Pakistan
Watsons Personal Care Stores (Philippines), Inc.Importer: Sahar International Trading Inc.
DRP-10266-02
Dec 1, 2030
NoneTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
—
DR-XY44348
Mar 19, 2030
NoneTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
TGP Pharma Inc.Importer: Philgen Pharmaceuticals, Inc.
DRP-11040-03
Jan 12, 2027
NoneTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Bansan Pharma DistributorImporter: Philgen Pharmaceuticals Inc.
DRP-11040-05
Jan 12, 2027
NoneTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
South Star DrugTrader: Dr. Zen's Research, Inc.
DRP-14387-01
Aug 31, 2028
NoneTelmisartan
80 mg TabletAlu/Alu Blister Pack of 3’s x 10's (Box of 30's)
RxVAT-exempt
Scott-Edil Pharmacia LimitedIndia
Alkem Laboratories CorporationImporter: Pharmakon Biotec Inc.
DRP-4762-08
Sep 30, 2028
NoneTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 28's, 30's and 100's)
RxVAT-exempt
Evertogen Life Sciences LimitedIndia
RITEMED PHILS., INC.Importer: MEDINOVA PHARMACEUTICAL INC.
DRP-8338
May 7, 2029
NormitechTelmisartan
40 mg TabletAlu/ (CPV / Alu/ OPA)/ Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Globela Pharma Private LimitedIndia
SNV Biotech Medicinal Products WholesalingImporter: AMB HK Enterprises Inc.
DRP-13017-01
Nov 17, 2027
NovazartTelmisartan
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Saludcare (I) Pvt. Ltd.India
Medinova Pharmaceutical Inc.
DRP-16225
Sep 19, 2029
OnmarcTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Ellebasy Medicale Group Inc.Importer: Orange Biotec Inc.
DRP-3212-08
Aug 24, 2029
OnmarcTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Ellebasy Medicale Group Inc.Importer: Orange Biotec Inc.
DRP-3207-06
Aug 24, 2029
OP-TelmisTelmisartan
40 mg TabletAlu/(PVC/Alu/OPA)/Alu Blister Pack of 10’s (Box of 30’s)
RxVAT-exempt
Globela Pharma Private LimitedIndia
Orient Pearl Med Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-10475-05
Sep 30, 2031
OP-TELMISTelmisartan
80 mg TabletAlu/Alu Blister Pack of 30's x 10's (Box of 30's)
RxVAT-exempt
Scott-Edil Pharmacia LimitedIndia
Orient Pearl Med Pharma Inc.Importer: Pharmakon Biotec Inc.
DRP-4762-12
Sep 30, 2028
Oppisartan-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Orientphil Pharma Inc.Importer: Ambica International Corporation
DRP-3687-07
May 3, 2032
Oppisartan-80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10’s (Box of 10’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Orientphil Pharma Inc.Importer: Ambica International Corporation
DRP-3710-06
Mar 29, 2032
Oratel-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Suhitas Pharmaceuticals Inc.Importer: Orange Biotec Inc.
DRP-3212-07
Aug 24, 2029
Oratel-80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Suhitas Pharmaceuticals Inc.Importer: Orange Biotec Inc.
DRP-3207-05
Aug 24, 2029
Retaguard 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Reta DrugImporter: Orange Biotec Inc.
DRP-3212-13
Aug 24, 2029
Retaguard 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Reta DrugImporter: Orange Biotec Inc.
DRP-3207-10
Aug 24, 2029
RhandesartanTelmisartan
40 mg TabletAlu/PVC Blister Pack x 14’s in a Polyester/Aluminum/ Polyethylene Bag (Box of 28’s) Alu/PVC Blister Pack x 10’s in a Polyester/Aluminum/ Polyethylene Bag (Box of 30’s)
RxVAT-exempt
Zhejiang Jingxin Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-17052
Sep 15, 2030
RhandesartanTelmisartan
80 mg TabletAlu/PVC Blister Pack x 10’s in a Polyester/ Aluminum/ Polyethylene Bag (Box of 30’s)
RxVAT-exempt
Zhejiang Jingxin Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-17053
Sep 15, 2030
RhetizarTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-3687-09
May 3, 2027
Saphmis-GE40Telmisartan
40 mg Tablet
RxVAT-exempt
Genom Biotech Pvt. Ltd.India
Nelpa Lifesciences, Inc.
DRP-17704
Feb 20, 2031
Saphmis-GE80Telmisartan
80 mg Tablet
RxVAT-exempt
Genom Biotech Pvt. Ltd.India
Nelpa Lifesciences, Inc.
DRP-17703
Feb 20, 2031
T-SartanTelmisartan
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's)
RxVAT-exempt
Maple Pharmaceuticals (Pvt.) Ltd.Pakistan
AGB Pharmaceutical Trading and Consultancy Corporation
DRP-4708
Sep 12, 2028
T-SartanTelmisartan
40 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s (Box of 14’s and 28’s)
RxVAT-exempt
Maple Pharmaceuticals Pvt. Ltd.Pakistan
Medlink Pharma Phils., Inc.Importer: AGB Pharmaceutical Trading and Consultancy Corporation
DRP-9708
May 11, 2031
T-SartanTelmisartan
80 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's)
RxVAT-exempt
Maple Pharmaceuticals (Pvt.) Ltd.Pakistan
AGB Pharmaceutical Trading and Consultancy Corporation
DRP-4558
Jul 24, 2028
Tartan 40Telmisartan
40mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Agio Pharmaceuticals Ltd.India
Macropharma Corporation
DRP-13954
May 25, 2028
Tartan 80Telmisartan
80mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Agio Pharmaceuticals Ltd.India
Macropharma Corporation
DRP-13953
May 25, 2028
TelarbTelmisartan
40 mg TabletAlu/Alu Blister Pack of 3's x 10's (Box of 30's)
RxVAT-exempt
Scott-Edil Pharmacia Ltd.India
The Cathay YSS Distributors Co., Inc.Importer: Pharmakon Biotec Inc.
DRP-4765-07
Sep 30, 2028
TelarbTelmisartan
80 mg TabletAlu/Alu Blister Pack of 3's x 10's (Box of 30's)
RxVAT-exempt
Scott-Edil Pharmacia LimitedIndia
The Cathay YSS Distributors Co., Inc.Importer: Pharmakon Biotec Inc.
DRP-4762-06
Sep 30, 2028
TelatrazTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Alembic Pharmaceuticals LimitedIndia
Natrapharm Inc
DR-XY478942
Nov 29, 2028
TelatrazTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Alembic Pharmaceuticals LimitedIndia
Natrapharm Inc.
DR-XY48941
Nov 29, 2028
Telbip 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Evertogen Life Sciences LimitedIndia
K Pharma Medical Corp.Importer: Medinova Pharmaceutical Inc.
DRP-8339-04
May 7, 2029
Telcor 40Telmisartan
40 mg Film-Coated TabletAlu/Alu Blsiter Pack x 10's (Box of 30's) (Box of 100's)
RxVAT-exempt
Mars Therapeutics Private LimitedIndia
Sanimed Pharmaceuticals Inc.Importer: Hillcross Prime, Inc.
DRP-9390-08
Mar 2, 2031
Telcor 80Telmisartan
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's
RxVAT-exempt
Mars Therapeutics Private LimitedIndia
Sanimed Pharmaceuticals Inc.Importer: Hillcross Prime, Inc.
DRP-9391-05
Mar 2, 2031
Telday-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Torrent Pharmaceuticals Ltd.India
Torrent Pharma Philippines, Inc.
DR-XY42004
May 6, 2028
Telday-80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Torrent Pharmaceuticals Ltd.India
Torrent Pharma Philippines Inc
DR-XY42005
May 6, 2028
TeldraTelmisartan
40 mg TabletAlu/Alu blister pack x 10's (Box of 30's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Bell-Kenz Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP–15838-01
Sep 20, 2029
TeldraTelmisartan
80 mg TabletAlu/Alu blister pack x 10's (Box of 30's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Bell-Kenz Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-15839-01
Sep 20, 2029
Telfocus 40Telmisartan
40 mg TabletTriple Laminated Cold Form Alu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Aurobindo Pharma Limited (Unit VII)India
Medethix, Inc.
DRP-13447
Feb 22, 2031
Telfocus 80Telmisartan
80 mg TabletTriple Laminated Cold Form Alu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Aurobindo Pharma Limited (UNIT VII)India
Medethix, Inc.
DRP-11184
Feb 16, 2032
Telfort 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
PH Phil Asia Medica Co.Importer: Pharmakon Biotec Inc.
DRP-16792-13
Jul 11, 2030
Telfort 80Telmisartan
80 mg TabletAlu/Alu Blister Pack of 3's x 10's (Box of 30's)
RxVAT-exempt
Scott-Edil Pharmacia LimitedIndia
PH Phil Asia Medica Co.Importer: Pharmakon Biotec Inc.
DRP-4762-13
Sep 30, 2028
TelgioTelmisartan
40 mg TabletOPA/Aluminum/PVC Blister pack x 10's (Box of 30's)
RxVAT-exempt
PT Dexa MedicaIndonesia
Glorious Dexa Mandaya, Inc.
DRP-12205
Jul 1, 2027
TelgioTelmisartan
80 mg TabletOPA/Aluminum/PVC Blister pack x 10's (Box of 30's)
RxVAT-exempt
PT Dexa MedicaIndonesia
Glorious Dexa Mandaya, Inc.
DRP-12206
Jul 1, 2027
TelgipTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
The Acme Laboratories LimitedBangladesh
Euro Generics International Phils., Inc.
DR-XY49365
Apr 4, 2030
TelgipTelmisartan
80 mg TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
The ACME Laboratories LimitedBangladesh
Euro Generics International Philippines, Inc.
DRP-17530
Apr 4, 2030
Telgrand-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Grandis Pharma IncorporatedImporter: Pharmakon Biotec Inc.
DRP-16792-02
Jul 11, 2030
TelguardTelmisartan
20 mg TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Indchemie Health Specialties Private LimitedIndia
Suhitas Pharmaceuticals Inc.
DRP-18376
Jun 24, 2031
TelguardTelmisartan
40 mg TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Indchemie Health Specialties Private LimitedIndia
Suhitas Pharmaceuticals Inc.
DRP-18375
Jun 24, 2031
TelguardTelmisartan
80 mg TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Indchemie Health Specialties Private LimitedIndia
Suhitas Pharmaceuticals Inc.
DRP-18374
Jun 24, 2031
Teli 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Cadila Pharmaceuticals LimitedIndia
Macropharma CorporationImporter: Ambica International Corporation
DRP-4789
Oct 4, 2028
Teli 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Cadila Pharmaceuticals LimitedIndia
Macropharma CorporationImporter: Ambica International Corporation
DRP-4790
Oct 4, 2028
TeliDril 20Telmisartan
20 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Aldril Pharmaceuticals, Inc.
DRP-14386
Aug 31, 2028
TeliDril 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Aldril Pharmaceuticals, Inc.
DRP-14385
Aug 31, 2028
Telidril 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Aldril Pharmaceuticals Inc.
DRP-14384
Aug 31, 2028
TeliGen-20Telmisartan
20 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-14383
Aug 31, 2028
TeliGen-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-14382
Aug 31, 2028
TeliGen-80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-14381
Aug 31, 2028
Telimac 40Telmisartan
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) (Box of 100's)
RxVAT-exempt
Mars Therapeutics Private LimitedIndia
Sanimed Pharmaceuticals Inc.Importer: Hillcross Prime, Inc.
DRP-9390-10
Mar 2, 2031
Telimac 80Telmisartan
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Mars Therapeutics Private LimitedIndia
Sanimed Pharmaceuticals Inc.Importer: Hillcross Prime, Inc.
DRP-9391-07
Mar 2, 2031
Telisan 40Telmisartan
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Mars Therapeutics Private LimitedIndia
Prohansen Pharma Phils. Inc.Importer: Hillcross Prime, Inc.
DRP-9390-04
Mar 2, 2031
Telisan 80Telmisartan
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Mars Therapeutics Private LimitedIndia
Prohansen Pharma Phils.Importer: Hillcross Prime, Inc.
DRP-9391-02
Mar 2, 2031
TelisolvTelmisartan
20 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Solvang Pharmaceuticals. Inc.
DRP-14380
Aug 31, 2028
TelisolvTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Solvang Pharmaceuticals, Inc.
DRP-14379
Aug 31, 2028
TelisolvTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Solvang Pharmaceuticals, Inc.
DRP-14378
Aug 31, 2028
TelmanTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Littman Drug CorporationImporter: Orange Biotec Inc.
DRP-3212-09
Aug 24, 2029
TelmanTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Littman Drug CorporationImporter: Orange Biotec Inc.
DRP-3207-08
Aug 24, 2029
TelmaxTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Crisdy-Na Drug Corporation
DRP-6176-03
Jan 23, 2030
TelmaxTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Crisdy-Na Drug Corporation
DRP-6742-04
Mar 23, 2030
Telmaxa-80Telmisartan
80 mg Film-Coated TabletAlu/Alu Blister Pack X 10's (Box of 100' and 30's)
RxVAT-exempt
Saludcare (I) Pvt. Ltd.India
GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc.
DRP-16225-01
Dec 19, 2029
TelmefixxTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
D&G PharmaImporter: Ambica International Corporation
DRP-3687-04
May 3, 2032
TelmezTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Ajanta Pharma LimitedIndia
Ajanta Pharma Philippines, Inc.Importer: Ajanta Pharma Philippines Inc..
DR-XY47616
Dec 20, 2026
TelmezTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Ajanta Pharma LimitedIndia
Ajanta Pharma Philippines, Inc.
DRP-11522
Dec 20, 2031
TelmezTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Ajanta Pharma LimitedIndia
Ajanta Pharma Philippines, Inc.Importer: Ajanta Pharma Philippines Inc..
DR-XY47615
Dec 20, 2026
TelmezTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Ajanta Pharma LimitedIndia
Ajanta Pharma Philippines, Inc.
DRP-11524
Dec 20, 2031
TelmibetTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Better Option Pharmaceuticals, Inc.Importer: Orange Biotec Inc.
DRP-3212-06
Aug 24, 2029
TelmibetTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Better Option Pharmaceuticals, Inc.Importer: Orange Biotec Inc.
DRP-3207-03
Aug 24, 2029
Telmicard-20Telmisartan
20 mg TabletAlu/ Alu Blister Pack x 10's (Box of 10's)
RxVAT-exempt
Zim Laboratories Ltd.India
Ambicare Pharmaceuticals Inc.Trader: Rainbow Life Sciences Pvt. Ltd.
DRP-5869
Feb 17, 2032
Telmicard-40Telmisartan
40 mg TabletAlu/ Alu Blister Pack x 10's (Box of 10's)
RxVAT-exempt
Zim Laboratories Ltd.India
Ambicare Pharmaceuticals Inc.Trader: Rainbow Life Sciences Pvt. Ltd.
DRP-5867
Mar 19, 2032
TelmicassTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Evertogen Life Sciences LimitedIndia
Cassandras Care Pharmaceutical DistributorImporter: Medinova Pharmaceutical Inc.
DRP-8339-06
May 7, 2029
TelmicorTelmisartan
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Mars Therapeutics & Chemicals Ltd.India
Hillcross Prime, Inc.
DRP-9390
Mar 2, 2031
TelmicorTelmisartan
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Mars Therapeutics Private LimitedIndia
Hillcross Prime, Inc.
DRP-9391
Mar 2, 2031
Telmicura 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
RVM Pharma & Medical Supplies DistributionImporter: Orange Biotec Inc.
DRP-3212-15
Aug 24, 2029
Telmicura 80Telmisartan
80 mg TabletAlu / Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
RVM Pharma & Medical Supplies DistributionImporter: Orange Biotec Inc.
DRP-3207-11
Aug 24, 2029
Telmidec-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
HLM Pharmaceutical Inc.Importer: Orange Biotec Inc.
DRP-3212-03
Aug 24, 2029
Telmidec-80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
HLM Pharmaceutical Inc.Importer: Orange Biotec Inc.
DRP-3207-07
Aug 24, 2029
TelmidinTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Medchoice Endocrine Group, Inc.Importer: Ambica International Corporation
DRP-3687-05
May 3, 2027
TelmidinTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10’s (Box of 10’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Medchoice Endocrine Group, Inc.Importer: Ambica International Corporation
DRP-3710-04
Mar 29, 2032
Telmidis-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Healer's Lab. Unit IIIndia
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-5421-06
Aug 5, 2029
Telmidiv - 80Telmisartan
80mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Protech Biosystems Pvt. Ltd.India
Divjot Enterprises Corp.
DR-XY49831
Oct 27, 2031
Telmiem 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Novagen Healthcare Private LimitedIndia
I.E. Medica, Inc.
DRP-18114
May 7, 2028
Telmiem 80Telmisartan
80mg TabletAlu/Alu Blister x 10's (Box of 100's)
RxVAT-exempt
Novagen Healthcare Private LimitedIndia
I.E. Medica, Inc.Trader: Alvita Pharma Pvt. Ltd.
DRP-18112
May 6, 2031
TelmierraTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Sierra Pharmaceutical CorporationImporter: Orange Biotec Inc.
DRP-3212-11
Aug 24, 2029
TelmierraTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Sierra Pharmaceutical CorporationImporter: Orange Biotec Inc.
DRP-3207-09
Aug 24, 2029
Telmifast 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Healer's Lab Unit IIIndia
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-5421-14
Aug 5, 2029
Telmiflex-40Telmisartan
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Exemed PharmaceuticalsIndia
AMB HK Enterprises Inc.
DRP-17419
Jan 19, 2032
Telmiflex-80Telmisartan
80 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Exemed PharmaceuticalsIndia
AMB HK Enterprises Inc.
DRP-17170
Oct 10, 2031
TelmigenTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. LtdIndia
MeedPharma Medical Supplies and Equipment DistributorImporter: Philgen Pharmaceuticals Inc.
DRP-11041-06
Jan 12, 2027
TelmigetTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Getz Pharma (Phils.), Inc.
DRP-6176-02
Jan 23, 2030
TelmigetTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Getz Pharma (Phils.), Inc.
DRP-6742-03
Mar 23, 2030
Telmignan-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10’s (Box of 50’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-6364
Oct 2, 2030
Telmiheart 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Quad-Gen PharmaceuticalsImporter: Ambica International Corporation
DRP-3687-03
May 3, 2032
Telmiheart 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 10’s and 100’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-3710-02
Mar 29, 2032
TelmijazTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Jazmark PharmaceuticalImporter: Orange Biotec Inc.
DRP-3212-19
Aug 24, 2029
TelmijazTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Jazmark PharmaceuticalImporter: Orange Biotec Inc.
DRP-3207-12
Aug 24, 2029
Telminex-40Telmisartan
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Mars Therapeutics Private LimitedIndia
D'Conner PharmaImporter: Hillcross Prime, Inc.
DRP-9390-06
Mar 2, 2031
Telminex-80Telmisartan
Film-Coated Tablet 80 mgAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Mars Therapeutics Private LimitedIndia
D'Conner PharmaImporter: Hillcross Prime, Inc.
DRP-9391-04
Mar 2, 2031
Telminorm-80Telmisartan
80 mg TabletBlister Pack x 10's (Box of 30's)
RxVAT-exempt
Ipca Laboratories Ltd.India
Blue Global (FZE)
DRP-13106
Dec 1, 2027
Telminow 40Telmisartan
40mg TabletAlu-Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Cubit Lifesciences LLPIndia
Aglobal Care, Inc.
DRP-18686
Aug 24, 2031
Telminow 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Cubit Lifesciences LLPIndia
Aglobal Care, Inc.
DRP-15788
Sep 12, 2029
TelmiphilTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 10's)
RxVAT-exempt
Zim Laboratories Ltd.India
Phil Asia Pharma Inc.Importer: Ambicare Pharmaceuticals Inc.Trader: Rainbow Life Sciences Pvt. Ltd.
DRP-5867-01
Mar 19, 2032
TelmiraTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Healer’s Lab. Unit IIIndia
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-5421-05
Aug 5, 2029
TelmirichTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Medirich Pharma Distribution Corp.Importer: Orange Biotec Inc.
DRP-3212-16
Aug 24, 2029
Telmiride-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Unison Pharmaceuticals Pvt. Ltd.India
Macropharma Corporation
DRP-16886
Aug 8, 2030
Telmiride-80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Unison Pharmaceuticals Pvt. Ltd.India
Macropharma Corporation
DRP-16885
Aug 8, 2030
Telmirin 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Corbridge Group Phils., Inc.Importer: Orange Biotec Inc.
DRP-3207-04
Aug 24, 2029
Telmirx 40Telmisartan
40mg TabletAlu/ (PVC/Alu/OPA)/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Globela Pharma Private LimitedIndia
AMB HK Enterprises Inc.
DRP-13017
Nov 17, 2027
TELMISAPH-40Telmisartan
40 mg TabletAlu/Alu PVC Blister x 10's (Box of 30's)
RxVAT-exempt
Sapphire Lifesciences Pvt. LtdIndia
Nelpa Lifesciences, Inc.
DRP-9616
Mar 25, 2031
Telmisaph-80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Sapphire Lifesciences Pvt. LtdIndia
Nelpa Lifesciences, Inc.
DRP-9615
Mar 25, 2031
TelmisarTelmisartan
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Euroasia Pharmaceuticals, IncTrader: Tunic Healthcare
DRP-10115
Jun 17, 2030
Telmisar 80Telmisartan
80 mg film-coated tabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Euroasia Pharmaceuticals Inc.Trader: Tunic Healthcare
DRP-10113
Feb 26, 2031
TelmispecTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10’s Box of 100’s
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Pharmaspec N.A., Inc.
DRP-6176-04
Jan 23, 2030
Telmistal-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10’s (Box of 30’s); Alu/Alu Blister Pack x 10’s (Box of 2's, 5's and 10's as Physician's Sample)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
HealthPrescription, Inc.Importer: Ambica International Corporation
DRP-3687
May 3, 2032
Telmistal-80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 10’s, 30’s and 100’s); Alu/Alu Blister Pack x 10's (Box of 2’s, 5’s and 10’s as Physician Sample)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
HealthPrescription, Inc.Importer: Ambica International Corporation
DRP-3710
Mar 29, 2032
Telmitar 40Telmisartan
40 mg TabletAlu/Alu blister pack x 10 tablets (Box of 30 tablets)
RxVAT-exempt
Hetero Labs Limited (Unit V)India
Camber Pharmaceuticals, Inc.
DRP-10423
Oct 25, 2031
Telmitar 80Telmisartan
80 mg TabletAlu/Alu blister pack x 10 tablets (Box of 30 tablets)
RxVAT-exempt
Hetero Labs Limited (Unit V)India
Camber Pharmaceuticals, Inc.
DRP-10424
Oct 25, 2031
TelmitimeTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Rx Time Pharma CorporationImporter: Orange Biotec Inc.
DRP-3212-14
Aug 24, 2029
TelmivascTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-16792-04
Jul 11, 2030
Telmiver-40Telmisartan
40 mg Film-Coated TabletAlu/Alu Blister Pack X 10'S (Box Of 30'S And Box Of 100'S)
RxVAT-exempt
Kausik Therapeutics (P) Ltd.India
Brel Pharmaceutical Inc.
DRP-19104
Oct 28, 2031
Telmiver-80Telmisartan
80 mg Film-Coated TabletAlu-Alu Blister Pack X 10'S (Box Of 30'S And Box Of 100'S)
RxVAT-exempt
Kausik Therapeutics (P) Ltd.India
Brel Pharmaceutical Inc
DRP-19105
Oct 28, 2031
TelmixedTelmisartan
40 mg TabletAlu/Alu PVC Blister x 10's (Box of 30's
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc.
DRP-9616-04
Mar 25, 2031
TelmizartTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Medhaus Pharma, Incorporated
DR-XY48861
Aug 31, 2028
Telmizen 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-16792-06
Jul 11, 2030
Telmyr-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-16792-08
Jul 11, 2030
TELOD 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India
S.M.H.P. Marketing & Consultancy
DRP-16782
Jul 10, 2030
Telsar 40Telmisartan
40 mg TabletAlu/Alu Foil Strip of 10's (Box of 30's)
RxVAT-exempt
Unichem Laboratories LimitedIndia
Healol Pharma Corporation
DRP-11540
Mar 10, 2029
Telsar-80Telmisartan
80 mg TabletAluminum Strip Foil x 10's (Box of 30's)
RxVAT-exempt
Unichem Laboratories LimitedIndia
Healol Pharma Corporation
DRP-8548
Nov 20, 2028
TelsartanTelmisartan
40 mg TabletAluminum Foil Strip x 10's Box of 30's
RxVAT-exempt
Bal Pharma LimitedIndia
ENDURE MEDICAL, INC.Importer: SINGAPORE GENEBIO, INC.
DR-XY45378
May 11, 2031
Telsartin 40Telmisartan
40 mg TabletAlu/Alu Blister Pack X 10'S (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Ultramed Pharma, Inc
DR-XY48846
Aug 14, 2028
Telsartin 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Ultramed Pharma, Inc.
DR-XY48843
Aug 10, 2028
TelsicareTelmisartan
40 mg Film Coated TabletAlu/Alu blister Pack of 10's (Box of 100's)
RxVAT-exempt
Macter International LtdKarachi 75700 Pakistan
Medcare PharmaceuticalsImporter: Sahar International Tradining Inc.
DRP-12323-02
Jun 30, 2036
Telsicare-80Telmisartan
80 mg Film-Coated TabletBox of 1 Alu-Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Macter InternationalPakistan
Medcare PharmaceuticalsImporter: Sahar International Trading Inc.
DRP-10266-03
Dec 1, 2030
Telsitan-20Telmisartan
20mg Film-Coated TabletBox of 1 Alu-Alu Blister Pack x 10's and 100's Box of 10's; Box of 100's
RxVAT-exempt
Macter International Ltd.Pakistan
Sahar International Trading, Inc
DRP-10270
Dec 1, 2030
Telsitan-40Telmisartan
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 30's and 100's)
RxVAT-exempt
—
Sahar International Trading Inc.
DRP-12323
Jun 30, 2031
Telsitan-80Telmisartan
80mg Film-Coated TabletBox of 1 Alu-Alu Blister Pack x 10's and 100's Not Applicable
RxVAT-exempt
Macter International Ltd.Pakistan
Sahar International Trading, Inc.
DRP-10266
Dec 1, 2030
Telstar 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
GX International, Inc.
DRP-6176-01
Jan 23, 2030
Telstar 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
GX International, Inc.
DRP-6742-01
Mar 23, 2030
TelsynTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-16792-10
Jul 11, 2030
TeltanTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories Inc.Philippines
Trader: SEA-King Pharma Inc.
DR-XY49577
Jun 4, 2031
Telvakon-40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India 174101
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-16792-03
Jul 11, 2030
TelvestaTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Health Care Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-16792-09
Jul 11, 2030
Telwin 40Telmisartan
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Mars Therapeutics Private LimitedIndia
Tazio Lifescience Inc.Importer: Hillcross Prime, Inc.
DRP-9390-02
Mar 2, 2031
Telwin 80Telmisartan
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Mars Therapeutics Private LimitedIndia
Tazio Lifescience Inc.Importer: Hillcross Prime, Inc.
DRP-9391-01
Mar 2, 2031
TelzelTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Healer’s Lab. Unit IIIndia
Zeldix Pharma Inc.Importer: Pharmakon Biotec Inc.
DRP-5421-12
Aug 24, 2029
Telzyd 20Telmisartan
20 mg TabletAlu/Alu Blister Pack x 10's Box of 30's; Alu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Zydus Lifesciences LimitedIndia
Zydus Healthcare Philippines Inc.
DRP-8199
Jun 8, 2031
Telzyd 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Theon Pharmaceuticals Ltd.India
Zydus Healthcare Philippines Inc.Importer: Orange Biotec Inc.
DRP-3212-02
Aug 24, 2029
Telzyd 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100’s)
RxVAT-exempt
Zydus Lifesciences LimitedIndia
Zydus Healthcare Philippines, Inc.
DRP-8200
Jun 8, 2031
TenomexTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-16792-07
Jul 11, 2030
TerasartTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-16792-12
Jul 11, 2030
TerasartTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Healer's Lab Unit IIIndia
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-5421-02
Aug 5, 2029
TerasartTelmisartan
80 mg TabletAlu/Alu Blister Pack of 3's x 10's (Box of 30's)
RxVAT-exempt
Scott-Edil Pharmacia Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-4762-11
Sep 30, 2028
TerlisartanTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Healer's Lab Unit IIIndia
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec, Inc.
DRP-5421-03
Aug 5, 2029
TerlisartanTelmisartan
80 mg TabletAlu/Alu Blister Pack of 3's x 10's (Box of 30's)
RxVAT-exempt
Scott-Edil Pharmacia LimitedIndia
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-4762-09
Sep 30, 2028
TesarTelmisartan
40 mg TabletAlu/Alu Blister Pack of 3's x 10's (Box of 30's)
RxVAT-exempt
Scott-Edil Pharmacia Ltd.India
Pharmakon Biotec Inc.
DRP-4765
Sep 30, 2028
TesarTelmisartan
80 mg TabletAlu/Alu Blister Pack of 3's x 10's (Box of 30's)
RxVAT-exempt
Scott-Edil Pharmacia LimitedIndia
Pharmakon Biotec Inc.
DRP-4762
Sep 30, 2028
TesarmizTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10’s (Box of 10’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-3710-03
Mar 29, 2032
Tevex 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
AMN Life Pvt. Ltd.India
VE Pharma Inc.Trader: Vexxa Lifesciences Pvt. Ltd.
DR-XY49387
Apr 28, 2030
Tevex 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
AMN Life Pvt. Ltd.India
VE Pharma Inc.Trader: Vexxa Lifesciences Pvt. Ltd.
DR-XY49386
Apr 28, 2030
Tevilyst 80Telmisartan
80 mg TabletAlu/Alu Blister pack x 10's
RxVAT-exempt
Inventia Healthcare LimitedIndia
Phagrosea Corporation
DRP-14726
Dec 14, 2028
Thelz-80Telmisartan
80 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14’s)
RxVAT-exempt
Maple Pharmaceuticals (Pvt.) Ltd.Pakistan
Ambitech Biopharmaceuticals Inc.Importer: AGB PHARMACEUTICAL TRADING AND CONSULTANCY CORPORATION
DRP-4558-01
Jul 24, 2028
Tsartan 40Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Orange Biotec Inc.
DRP-15417
Jul 5, 2029
Tsartan 80Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Orange Biotec Inc.
DRP-15416
Jul 5, 2029
UnbrandedTelmisartan
40 mg Film Coated TabletAlu/Alu Blister pack of 10's [Box of 100's, 30's; and 10's]
RxVAT-exempt
Macter International Ltd.75700 Pakistan
Watsons Personal Care Stores (Philippines), IncImporter: Sahar International Trading Inc.
DRP-12323-03
Jun 30, 2031
UnbrandedTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 10's and 30's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Philgen Pharmaceuticals Inc.
DRP-11041
Jan 12, 2032
UnbrandedTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Rose Pharmacy, IncorporatedImporter: Ambica International Corporation
DRP-3687-08
May 3, 2032
UnbrandedTelmisartan
40 mg TabletAlu/Alu PVC Blister x 10's (Box of 30's)
RxVAT-exempt
Sapphire Lifesciences Pvt. LtdIndia
Watsons Personal Care Stores (Philippines), Inc.Importer: Nelpa Lifesciences, Inc.
DRP-9616-01
Mar 25, 2031
UnbrandedTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 10's and 30's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Philgen Pharmaceuticals Inc.
DRP-11040
Jan 12, 2032
UnbrandedTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories Inc.Philippines
Trader: Metz Pharmaceuticals, Inc.
DRP-13215
Dec 9, 2032
UnbrandedTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10’s (Box of 10’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Rose Pharmacy, IncorporatedImporter: Ambica International Corporation
DRP-3710-07
Mar 29, 2032
UnbrandedTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
—
DRP-6742
Mar 23, 2030
UnbrandedTelmisartan
80mg TabletOPA/Aluminum/PVC Blister pack x 10's (Box of 30’s)
RxVAT-exempt
PT Dexa MedicaIndonesia
Actimed, Inc.Importer: Glorious Dexa Mandaya, Inc.
DRP-12206-01
Jul 1, 2027
UnbrandedTelmisartan
Tablet 80 mgAlu/Alu Blister x 10's (Box of 30's)
RxVAT-exempt
Sapphire Lifesciences Pvt. LtdIndia
Watsons Personal Care Stores (Philippines), Inc.Importer: Nelpa Lifesciences, Inc.Trader: IMT Fine Nutrition Marketing
DRP-9615-01
Mar 25, 2031
Vas8Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Healer's Lab. Unit IIIndia
Conjug8 Corp.Importer: Pharmakon Biotec Inc.
DRP-5421-07
Aug 5, 2029
Vas8Telmisartan
80 mg TabletAlu/Alu Blister Pack of 3’s x 10's (Box of 30's)
RxVAT-exempt
Scott-Edil Pharmacia LimitedIndia
Conjug8 Corp.Importer: Pharmakon Biotec Inc.
DRP-4762-07
Sep 30, 2028
VicardisTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. LtdIndia
Vitalife Pharma & Medical Supply Inc.Importer: Philgen Pharmaceuticals, Inc
DRP-11041-02
Jan 12, 2027
VicardisTelmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. LtdIndia
Vitalife Pharma & Medical Supply Inc.Importer: Philgen Pharmaceuticals Inc.
DRP-11040-02
Jan 12, 2027
XytelTelmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Prosel Pharmaceutical & Distributors, Inc.
DR-XY49418
Jun 5, 2030
XytelTelmisartan
80 mg TabletStore at temperatures not exceeding 30°C. : Alu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Prosel Pharmaceuticals & Distributors, Inc.
DR-XY49417
Jun 5, 2030
ZermisarTelmisartan
40 mg TabletAlu/Alu Blister Pack of 3's x 10's (Box of 30's)
RxVAT-exempt
Scott-Edil Pharmacia Ltd.India
Hale Medipoint Corp.Importer: Pharmakon Biotec Inc.
DRP-4765-09
Sep 30, 2028
ZermisarTelmisartan
80 mg TabletAlu/Alu Blister Pack of 3's x 10's (Box of 30's)
RxVAT-exempt
Scott-Edil Pharmacia LimitedIndia
Hale Medipoint Corp.Importer: Pharmakon Biotec Inc.
DRP-4762-10
Sep 30, 2028
(no brand name)Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Intas Pharmaceuticals LimitedIndia
Onesource Pharma Solutions, Inc.
DRP-11048
Jan 19, 2027
(no brand name)Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Dr. Zen's Research, Inc.
DRP-14388
Aug 31, 2028
(no brand name)Telmisartan
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Novagen Healthcare Private LimitedIndia
I.E. Medica, Inc.Trader: Alvita Pharma Pvt. Ltd
DRP-18113
May 7, 2028
(no brand name)Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DR-XY48524
Dec 9, 2027
(no brand name)Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Intas Pharmaceuticals LimitedIndia
Onesource Pharma Solutions, Inc.
DRP-11047
Jan 19, 2027
(no brand name)Telmisartan
80 mg TabletTriple Laminated Cold Form Alu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Aurobindo Pharma Limited (Unit VII)India
Medethix, Inc.
DRP-11148
Feb 10, 2027
(no brand name)Telmisartan
80 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Dr. Zen's Research, Inc.
DRP-14387
Aug 31, 2028
(no brand name)Telmisartan
80mg TabletAlu/Alu Blister x 10's (Box of 30's)
RxVAT-exempt
Novagen Healthcare Private LimitedIndia
I.E. Medica, Inc.Trader: Alvita Pharma Pvt. Ltd.
DRP-18111
May 6, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

United States (label)

Dosage forms and strengths (US label) US FDA label

3 DOSAGE FORMS AND STRENGTHS • 20 mg, White to off white, round shaped, uncoated tablets, debossed with "CL 45" on one side and plain on other side • 40 mg, White to off white, oval shaped, uncoated tablets, debossed with "CL 46" on one side and plain on other side • 80 mg, White to off white, oval shaped, uncoated tablets, debossed with "CL 47" on one side and plain on other side Tablets: 20 mg, 40 mg, 80 mg (3)

Warnings/Precautions

The boxed warning is shown at the top of this page.

Warnings and precautions (US label) US FDA label
  • Avoid fetal or neonatal exposure (5.1)
  • Hypotension: Correct any volume or salt depletion before initiating therapy. Observe for signs and symptoms of hypotension (5.2)
  • Monitor carefully in patients with impaired hepatic (5.4)
  • or renal function (5.5)
  • Avoid concomitant use of an ACE inhibitor and angiotensin receptor blocker (5.6)
5.1 Fetal Toxicity

5.1 Fetal Toxicity Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations. Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death.

When pregnancy is detected, discontinue telmisartan tablets as soon as possible [see Use in Specific Populations (8.1)].

5.2 Hypotension

5.2 Hypotension In patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of therapy with telmisartan tablets. Either correct this condition prior to administration of telmisartan tablets, or start treatment under close medical supervision with a reduced dose.

If hypotension does occur, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline. A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized.

5.3 Hyperkalemia

5.3 Hyperkalemia Hyperkalemia may occur in patients on ARBs, particularly in patients with advanced renal impairment, heart failure, on renal replacement therapy, or on potassium supplements, potassium-sparing diuretics, potassium-containing salt substitutes or other drugs that increase potassium levels. Consider periodic determinations of serum electrolytes to detect possible electrolyte imbalances, particularly in patients at risk.

5.4 Impaired Hepatic Function

5.4 Impaired Hepatic Function As the majority of telmisartan is eliminated by biliary excretion, patients with biliary obstructive disorders or hepatic insufficiency can be expected to have reduced clearance. Initiate telmisartan at low doses and titrate slowly in these patients [see Use in Specific Populations (8.6) and Clinical Pharmacology (12.3)].

5.5 Impaired Renal Function

5.5 Impaired Renal Function As a consequence of inhibiting the renin-angiotensin-aldosterone system, anticipate changes in renal function in susceptible individuals. In patients whose renal function may depend on the activity of the renin-angiotensin-aldosterone system (e.g., patients with severe congestive heart failure or renal dysfunction), treatment with angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death.

Similar results have been reported with telmisartan [see Clinical Pharmacology (12.3)]. In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen were observed. There has been no long-term use of telmisartan in patients with unilateral or bilateral renal artery stenosis, but anticipate an effect similar to that seen with ACE inhibitors.

5.6 Dual Blockade of the Renin-Angiotensin-Aldosterone System (RAS)

5.6 Dual Blockade of the Renin-Angiotensin-Aldosterone System (RAS) Dual blockade of the RAS with angiotensin-receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. The ONTARGET trial enrolled 25,620 patients ≥55 years old with atherosclerotic disease or diabetes with end-organ damage, randomizing them to telmisartan only, ramipril only, or the combination, and followed them for a median of 56 months.

Patients receiving the combination of telmisartan tablets and ramipril did not obtain any additional benefit compared to monotherapy, but experienced an increased incidence of renal dysfunction (e.g., acute renal failure) compared with groups receiving telmisartan alone or ramipril alone. In most patients no benefit has been associated with using two RAS inhibitors concomitantly.

In general, avoid combined use of RAS inhibitors. Closely monitor blood pressure, renal function, and electrolytes in patients on telmisartan tablets and other agents that affect the RAS. Do not co-administer aliskiren with telmisartan tablets in patients with diabetes. Avoid concomitant use of aliskiren with telmisartan tablets in patients with renal impairment (GFR <60 mL/min/1.73 m²).

Drug interactions

Drug interactions (US label) US FDA label

7 DRUG INTERACTIONS Aliskiren: Do not co-administer aliskiren with telmisartan in patients with diabetes. Avoid use of aliskiren with telmisartan in patients with renal impairment (GFR <60 mL/min). Digoxin: When telmisartan tablet was co-administered with digoxin, median increases in digoxin peak plasma concentration (49%) and in trough concentration (20%) were observed.

Therefore, monitor digoxin levels when initiating, adjusting, and discontinuing telmisartan for the purpose of keeping the digoxin level within the therapeutic range. Lithium: Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists including telmisartan.

Therefore, monitor serum lithium levels during concomitant use. Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including telmisartan, may result in deterioration of renal function, including possible acute renal failure.

These effects are usually reversible. Monitor renal function periodically in patients receiving telmisartan and NSAID therapy. The antihypertensive effect of angiotensin II receptor antagonists, including telmisartan may be attenuated by NSAIDs including selective COX-2 inhibitors.

  • NSAIDs: Increased risk of renal impairment and loss of anti-hypertensive effect (7)
  • Do not co-administer aliskiren with telmisartan tablets in patients with diabetes (7)
Metabolism and transporters (CYP, P-gp, OATP; US label) US FDA label

Telmisartan is not metabolized by the cytochrome P450 system and had no effects in vitro on cytochrome P450 enzymes, except for some inhibition of CYP2C19.

Telmisartan is not expected to interact with drugs that inhibit cytochrome P450 enzymes; it is also not expected to interact with drugs metabolized by cytochrome P450 enzymes, except for possible inhibition of the metabolism of drugs metabolized by CYP2C19.

Adverse reactions

Adverse reactions (US label) US FDA label
  • The following adverse reaction is described elsewhere in labeling: Renal dysfunction upon use with ramipril [see Warnings and Precautions (5.6)] Hypertension: The most common adverse events (≥1%) reported in hypertension trials are back pain, sinusitis, and diarrhea (6.1)
  • Cardiovascular risk reduction: The serious adverse events (≥1%) reported in cardiovascular risk reduction trials were intermittent claudication and skin ulcer (6.1)
  • To report SUSPECTED ADVERSE REACTIONS, contact NorthStar Rx LLC at 1-800-206-7821 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
6.1 Clinical Trials Experience

6.1 Clinical Trials Experience Because clinical studies are conducted under widely varying conditions, adverse reactions rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice. Hypertension Telmisartan has been evaluated for safety in more than 3700 patients, including 1900 treated for over 6 months and more than 1300 for over one year.

Adverse experiences have generally been mild and transient in nature and have infrequently required discontinuation of therapy. In placebo-controlled trials involving 1041 patients treated with various doses of telmisartan (20 to 160 mg) monotherapy for up to 12 weeks, the overall incidence of adverse events was similar to that in patients treated with placebo.

Adverse events occurring at an incidence of ≥1% in patients treated with telmisartan and at a greater rate than in patients treated with placebo, irrespective of their causal association, are presented in Table 1. Table 1 Adverse Events Occurring at an Incidence of ≥1% in Patients Treated with Telmisartan and at a Greater Rate Than Patients Treated with Placebo Telmisartan n=1455 % Placebo n=380 % Upper respiratory tract infection 7 6 Back pain 3 1 Sinusitis 3 2 Diarrhea 3 2 Pharyngitis 1 0 In addition to the adverse events in the table, the following events occurred at a rate of ≥1% but were at least as frequent in the placebo group: influenza-like symptoms, dyspepsia, myalgia, urinary tract infection, abdominal pain, headache, dizziness, pain, fatigue, coughing, hypertension, chest pain, nausea, and peripheral edema.

Discontinuation of therapy because of adverse events was required in 2.8% of 1455 patients treated with telmisartan tablets and 6.1% of 380 placebo patients in placebo-controlled clinical trials. The incidence of adverse events was not dose-related and did not correlate with gender, age, or race of patients. The incidence of cough occurring with telmisartan in 6 placebo-controlled trials was identical to that noted for placebo-treated patients (1.6%).

In addition to those listed above, adverse events that occurred in more than 0.3% of 3500 patients treated with telmisartan monotherapy in controlled or open trials are listed below. It cannot be determined whether these events were causally related to telmisartan tablets: Autonomic Nervous System: impotence, increased sweating, flushing; Body as a Whole: allergy, fever, leg pain, malaise; Cardiovascular: palpitation, dependent edema, angina pectoris, tachycardia, leg edema, abnormal ECG; CNS: insomnia, somnolence, migraine, vertigo, paresthesia, involuntary muscle contractions, hypoesthesia; Gastrointestinal: flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disorders; Metabolic: gout, hypercholesterolemia, diabetes mellitus; Musculoskeletal: arthritis, arthralgia, leg cramps; Psychiatric: anxiety, depression, nervousness; Resistance Mechanism: infection, fungal infection, abscess, otitis media; Respiratory: asthma, bronchitis, rhinitis, dyspnea, epistaxis; Skin: dermatitis, rash, eczema, pruritus; Urinary: micturition frequency, cystitis; Vascular: cerebrovascular disorder; and Special Senses: abnormal vision, conjunctivitis, tinnitus, earache.

During initial clinical studies, a single case of angioedema was reported (among a total of 3781 patients treated). Clinical Laboratory Findings In placebo-controlled clinical trials, clinically relevant changes in standard laboratory test parameters were rarely associated with administration of telmisartan tablets. Hemoglobin: A greater than 2 g/dL decrease in hemoglobin was observed in 0.8% telmisartan patients compared with 0.3% placebo patients.

No patients discontinued therapy because of anemia. Creatinine: A 0.5 mg/dL rise or greater in creatinine was observed in 0.4% telmisartan patients compared with 0.3% placebo patients. One telmisartan-treated patient discontinued therapy because of increases in creatinine and blood urea nitrogen. Liver Enzymes: Occasional elevations of liver chemistries occurred in patients treated with telmisartan; all marked elevations occurred at a higher frequency with placebo.

No telmisartan-treated patients discontinued therapy because of abnormal hepatic function. Cardiovascular Risk Reduction Because common adverse reactions were well characterized in studies of telmisartan in hypertension, only adverse events leading to discontinuation and serious adverse events were recorded in subsequent studies of telmisartan for cardiovascular risk reduction.

In TRANSCEND (N=5926, 4 years and 8 months of follow-up), discontinuations for adverse events were 8.4% on telmisartan and 7.6% on placebo. The only serious adverse events at least 1% more common on telmisartan than placebo were intermittent claudication (7% vs 6%) and skin ulcer (3% vs 2%).

6.2 Postmarketing Experience

6.2 Postmarketing Experience The following adverse reactions have been identified during post-approval use of telmisartan. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate reliably their frequency or establish a causal relationship to drug exposure.

Blood and Lymphatic System Disorders: Anemia, eosinophilia, thrombocytopenia Gastrointestinal Disorders: Abdominal pain, diarrhea, dyspepsia, nausea General Disorders and Administration Site Conditions: Asthenia, chest pain, edema, face edema, fatigue, lower limb edema, pain, weakness Hepato-biliary: Abnormal hepatic function/liver disorder Immune System Disorders: Anaphylactic reaction, hypersensitivity Investigations: Increased CPK, uric acid increased Metabolism and Nutrition Disorders: Hyperkalemia, hypoglycemia (in diabetic patients), hyponatremia Musculoskeletal and Connective Tissue Disorders: Myalgia Nervous System Disorders: Dizziness, headache, syncope Renal and Urinary Disorders: Renal impairment including acute renal failure Reproductive System and Breast Disorders: Erectile dysfunction Respiratory, Thoracic and Mediastinal Disorders: Coughing Skin and Subcutaneous Tissue Disorders: Angioedema (with fatal outcome), angioneurotic edema, drug eruption (toxic skin eruption mostly reported as toxicoderma, rash, and urticaria), erythema, sweating increased, urticaria Vascular Disorder: Hypotension (including postural hypotension) Rare cases of rhabdomyolysis have been reported in patients receiving angiotensin II receptor blockers, including telmisartan.

Adverse reaction frequency tables (US label) US FDA label
Telmisartan n=1455 % Placebo n=380 %
Upper respiratory tract infection 7 6
Back pain 3 1
Sinusitis 3 2
Diarrhea 3 2
Pharyngitis 1 0

Pregnancy considerations

Pregnancy (US label) US FDA label

8.1 Pregnancy Risk Summary Telmisartan tablets can cause fetal harm when administered to a pregnant woman. Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death (see Clinical Considerations).

Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. Studies in rats and rabbits with telmisartan showed fetotoxicity only at maternally toxic doses (see Data).

When pregnancy is detected, discontinue telmisartan tablet as soon as possible. The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively.

Clinical Considerations Disease-associated maternal and/or embryo/fetal risk Hypertension in pregnancy increases the maternal risk for pre-eclampsia, gestational diabetes, premature delivery, and delivery complications (e.g., need for cesarean section, and post-partum hemorrhage). Hypertension increases the fetal risk for intrauterine growth restriction and intrauterine death.

Pregnant women with hypertension should be carefully monitored and managed accordingly. Fetal/Neonatal adverse reactions Use of drugs that act on the RAS in the second and third trimesters of pregnancy can result in the following: oligohydramnios, reduced fetal renal function leading to anuria and renal failure, fetal lung hypoplasia, skeletal deformations, including skull hypoplasia, hypotension, and death.

In the unusual case that there is no appropriate alternative to therapy with drugs affecting the renin-angiotensin system for a particular patient, apprise the mother of the potential risk to the fetus. In patients taking telmisartan tablets during pregnancy, perform serial ultrasound examinations to assess the intra-amniotic environment.

Fetal testing may be appropriate, based on the week of gestation. If oligohydramnios is observed, discontinue telmisartan tablets, unless it is considered lifesaving for the mother. Patients and physicians should be aware, however, that oligohydramnios may not appear until after the fetus has sustained irreversible injury.

Closely observe infants with histories of in utero exposure to telmisartan tablets for hypotension, oliguria, and hyperkalemia. If oliguria or hypotension occurs, support blood pressure and renal perfusion. Exchange transfusions or dialysis may be required as a means of reversing hypotension and/or substituting for disordered renal function [see Use in Specific Populations (8.4)].

Data Animal Data No teratogenic effects were observed when telmisartan was administered to pregnant rats at oral doses of up to 50 mg/kg/day and to pregnant rabbits at oral doses up to 45 mg/kg/day. In rabbits, embryolethality associated with maternal toxicity (reduced body weight gain and food consumption) was observed at 45 mg/kg/day [about 12 times the maximum recommended human dose (MRHD) of 80 mg on a mg/m 2 basis].

In rats, maternally toxic (reduction in body weight gain and food consumption) telmisartan doses of 15 mg/kg/day (about 1.9 times the MRHD on a mg/m 2 basis), administered during late gestation and lactation, were observed to produce adverse effects in neonates, including reduced viability, low birth weight, delayed maturation, and decreased weight gain. The no-observed-effect doses for developmental toxicity in rats and rabbits, 5 and 15 mg/kg/day, respectively, are about 0.64 and 3.7 times, on a mg/m2 basis, the maximum recommended human dose of telmisartan (80 mg/day).

Mechanism of action

12.1 Mechanism of Action Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the principal pressor agent of the renin-angiotensin system, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation, and renal reabsorption of sodium.

Telmisartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT 1 receptor in many tissues, such as vascular smooth muscle and the adrenal gland. Its action is therefore independent of the pathways for angiotensin II synthesis. There is also an AT 2 receptor found in many tissues, but AT 2 is not known to be associated with cardiovascular homeostasis.

Telmisartan has much greater affinity (>3,000 fold) for the AT 1 receptor than for the AT 2 receptor. Blockade of the renin-angiotensin system with ACE inhibitors, which inhibit the biosynthesis of angiotensin II from angiotensin I, is widely used in the treatment of hypertension. ACE inhibitors also inhibit the degradation of bradykinin, a reaction also catalyzed by ACE.

Because telmisartan does not inhibit ACE (kininase II), it does not affect the response to bradykinin. Whether this difference has clinical relevance is not yet known. Telmisartan does not bind to or block other hormone receptors or ion channels known to be important in cardiovascular regulation. Blockade of the angiotensin II receptor inhibits the negative regulatory feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and angiotensin II circulating levels do not overcome the effect of telmisartan on blood pressure.

US FDA label

Pharmacodynamics

Pharmacodynamics (US label) US FDA label

12.2 Pharmacodynamics In normal volunteers, a dose of telmisartan 80 mg inhibited the pressor response to an intravenous infusion of angiotensin II by about 90% at peak plasma concentrations with approximately 40% inhibition persisting for 24 hours. Plasma concentration of angiotensin II and plasma renin activity (PRA) increased in a dose-dependent manner after single administration of telmisartan to healthy subjects and repeated administration to hypertensive patients.

The once-daily administration of up to 80 mg telmisartan to healthy subjects did not influence plasma aldosterone concentrations. In multiple dose studies with hypertensive patients, there were no clinically significant changes in electrolytes (serum potassium or sodium), or in metabolic function (including serum levels of cholesterol, triglycerides, HDL, LDL, glucose, or uric acid).

In 30 hypertensive patients with normal renal function treated for 8 weeks with telmisartan 80 mg or telmisartan 80 mg in combination with hydrochlorothiazide 12.5 mg, there were no clinically significant changes from baseline in renal blood flow, glomerular filtration rate, filtration fraction, renovascular resistance, or creatinine clearance.

Pharmacokinetics

Half-life and elimination (verbatim, US label)

Telmisartan shows bi-exponential decay kinetics with a terminal elimination half-life of approximately 24 hours.

Metabolism and Elimination Following either intravenous or oral administration of 14 C-labeled telmisartan, most of the administered dose (>97%) was eliminated unchanged in feces via biliary excretion; only minute amounts were found in the urine (0.91% and 0.49% of total radioactivity, respectively).

Terminal half-life and total clearance appear to be independent of dose.

Pharmacokinetics (US label) US FDA label

12.3 Pharmacokinetics Absorption: Following oral administration, peak concentrations (C max) of telmisartan are reached in 0.5 to 1 hour after dosing. Food slightly reduces the bioavailability of telmisartan, with a reduction in the area under the plasma concentration-time curve (AUC) of about 6% with the 40 mg tablet and about 20% after a 160 mg dose.

The absolute bioavailability of telmisartan is dose dependent. At 40 mg and 160 mg, the bioavailability was 42% and 58%, respectively. The pharmacokinetics of orally administered telmisartan are nonlinear over the dose range 20 mg to 160 mg, with greater than proportional increases of plasma concentrations (C max and AUC) with increasing doses.

Telmisartan shows bi-exponential decay kinetics with a terminal elimination half-life of approximately 24 hours. Trough plasma concentrations of telmisartan with once daily dosing are about 10% to 25% of peak plasma concentrations. Telmisartan has an accumulation index in plasma of 1.5 to 2.0 upon repeated once daily dosing.

Distribution Telmisartan is highly bound to plasma proteins (>99.5%), mainly albumin and α 1 - acid glycoprotein. Plasma protein binding is constant over the concentration range achieved with recommended doses. The volume of distribution for telmisartan is approximately 500 liters indicating additional tissue binding. Metabolism and Elimination Following either intravenous or oral administration of 14 C-labeled telmisartan, most of the administered dose (>97%) was eliminated unchanged in feces via biliary excretion; only minute amounts were found in the urine (0.91% and 0.49% of total radioactivity, respectively).

Telmisartan is metabolized by conjugation to form a pharmacologically inactive acyl glucuronide; the glucuronide of the parent compound is the only metabolite that has been identified in human plasma and urine. After a single dose, the glucuronide represents approximately 11% of the measured radioactivity in plasma. The cytochrome P450 isoenzymes are not involved in the metabolism of telmisartan.

Total plasma clearance of telmisartan is >800 mL/min. Terminal half-life and total clearance appear to be independent of dose. Specific Populations Renal Insufficiency No dosage adjustment is necessary in patients with decreased renal function. Telmisartan is not removed from blood by hemofiltration and is not dialyzable [see Warnings and Precautions (5.5) and Dosage and Administration (2.1)].

Hepatic Insufficiency In patients with hepatic insufficiency, plasma concentrations of telmisartan are increased, and absolute bioavailability approaches 100% [see Warnings and Precautions (5.4) and Use in Specific Populations (8.6)]. Gender Plasma concentrations of telmisartan are generally 2 to 3 times higher in females than in males.

In clinical trials, however, no significant increases in blood pressure response or in the incidence of orthostatic hypotension were found in women. No dosage adjustment is necessary. Geriatric Patients The pharmacokinetics of telmisartan do not differ between the elderly and those younger than 65 years [see Dosage and Administration (2.1)].

Pediatric Patients Telmisartan pharmacokinetics have not been investigated in patients <18 years of age. Drug Interaction Studies Telmisartan Ramipril and Ramiprilat: Co-administration of telmisartan 80 mg once daily and ramipril 10 mg once daily to healthy subjects increases steady-state C max and AUC of ramipril 2.3-and 2.1-fold, respectively, and C max and AUC of ramiprilat 2.4-and 1.5-fold, respectively.

In contrast, C max and AUC of telmisartan decrease by 31% and 16%, respectively. When co-administering telmisartan and ramipril, the response may be greater because of the possibly additive pharmacodynamic effects of the combined drugs, and also because of the increased exposure to ramipril and ramiprilat in the presence of telmisartan.

Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen. Telmisartan is not metabolized by the cytochrome P450 system and had no effects in vitro on cytochrome P450 enzymes, except for some inhibition of CYP2C19.

Telmisartan is not expected to interact with drugs that inhibit cytochrome P450 enzymes; it is also not expected to interact with drugs metabolized by cytochrome P450 enzymes, except for possible inhibition of the metabolism of drugs metabolized by CYP2C19.

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Telmisartan 40 mg Tablet₱10.00–₱16.07Reference ₱13.62per tabletDPRI procurement range
Telmisartan 80 mg Tablet₱18.00–₱31.80Reference ₱25.00per tabletDPRI procurement range
40 mg tablet₱10.00per tabletPhilHealth GAMOT fixed fee
80 mg tablet₱13.75per tabletPhilHealth GAMOT fixed fee

PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Telmisartan
PNF listingOral: 40 mg and 80 mg tablet
PhilHealth GAMOTYes (listed since July 28, 2025)

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Telmisartan · Redpharm Drug [US FDA-approved label, version 1, July 23, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5743c58e-deab-ac93-e063-6294a90ac1eb
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  5. PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  6. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .